ConductScience.org, home

Paper6238616

Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

Ponder BA and 7 others. Br J Cancer, 1984. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer. Papers, record 6238616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6238616

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.
PubMed
Journal
Br J Cancer
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.71
iCite
Revised in PubMed
2019-05-15
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ponder BAB A
2Shearer RJR J
3Pocock RDR D
4Miller JJ
5Easton DD
6Chilvers CEC E
7Dowsett MM
8Jeffcoate SLS L

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoglutethimideMajor topic
CortisoneMajor topic
Prostatic NeoplasmsMajor topic
Adenocarcinoma
Aged
Androstenedione
Antineoplastic Combined Chemotherapy Protocols
Dehydroepiandrosterone
Dihydrotestosterone
Humans
Male
Middle Aged
Sleep Stages
Testosterone

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14290076Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action.J Clin Endocrinol Metab1967https://conductscience.org/library/papers/4290076PubMed
24107388Pituitary irradiation in advanced carcinoma of the prostate: analysis of 100 cases.Br J Urol1971https://conductscience.org/library/papers/4107388PubMed
34117197Bilateral adrenalectomy for palliative treatment of prostatic cancer.J Urol1972https://conductscience.org/library/papers/4117197PubMed
44422260Adrenal suppression in the treatment of carcinoma of the prostate.Br J Urol1974https://conductscience.org/library/papers/4422260PubMed
5765499Aminoglutethimide medical adrenalectomy for advanced prostatic carcinoma.J Urol1976https://conductscience.org/library/papers/765499PubMed
6562455Study of steroid-protein binding by a novel "two-tier" column employing Cibacron Blue F3G-A-Sepharose 4B. I-Sex hormone binding globulin.J Steroid Biochem1977https://conductscience.org/library/papers/562455PubMed
784866Transsphenoidal hypophysectomy for disseminated carcinoma of the prostate gland. Results in 53 patients.J Neurosurg1979https://conductscience.org/library/papers/84866PubMed
8219036Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.J Clin Invest1979https://conductscience.org/library/papers/219036PubMed
989206Half and total body radiation for carcinoma of the prostate.J Urol1979https://conductscience.org/library/papers/89206PubMed
10536467Serum aminoglutethimide levels: studies of serum half-life, clearance, and patient compliance.J Clin Pharmacol1979https://conductscience.org/library/papers/536467PubMed
116445225Chemotherapy programs of the National Prostatic Cancer Project (NPCP).Cancer1980https://conductscience.org/library/papers/6445225PubMed
127189791Chemotherapy of hormone-resistant stage D prostatic cancer.J Urol1980https://conductscience.org/library/papers/7189791PubMed
136159036Pituitary ablation in the relief of pain in advanced prostatic carcinoma.Br J Urol1980https://conductscience.org/library/papers/6159036PubMed
146453270Medical adrenalectomy with aminoglutethimide in the management of advanced breast cancer.Med J Aust1981https://conductscience.org/library/papers/6453270PubMed
156174204Phase II trial of tamoxifen in metastatic carcinoma of the prostate.Cancer1982https://conductscience.org/library/papers/6174204PubMed
166213633Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.J Clin Endocrinol Metab1982https://conductscience.org/library/papers/6213633PubMed
177171963Aminoglutethimide therapy for advanced carcinoma of the prostate.Br J Urol1982https://conductscience.org/library/papers/7171963PubMed
18263348Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.J Clin Endocrinol Metab1978https://conductscience.org/library/papers/263348PubMed
196221746Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6221746PubMed
206861082Chemohormonal therapy of metastatic prostate cancer. A pilot study.Cancer1983https://conductscience.org/library/papers/6861082PubMed

See all 24 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
24948872Roles for the backdoor pathway of androgen metabolism in prostate cancer response to castration and drug treatment.Int J Biol Sci2014https://conductscience.org/library/papers/24948872PubMed
7680986Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.Drugs1993https://conductscience.org/library/papers/7680986PubMed
3358910The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.Br J Cancer1988https://conductscience.org/library/papers/3358910PubMed
3048976Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.Drugs1988https://conductscience.org/library/papers/3048976PubMed
2201397Aromatase inhibition in advanced prostatic cancer: preliminary communication.Br J Cancer1990https://conductscience.org/library/papers/2201397PubMed
1637664Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer.Br J Cancer1992https://conductscience.org/library/papers/1637664PubMed
1493356Aromatase inhibitors in malignant diseases of aging.Drugs Aging1992https://conductscience.org/library/papers/1493356PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6238616

GET https://conductscience.org/api/papers/v1/6238616/references?page=2